Hadjadj S - Search Results

1

Empagliflozin mitigates metabolic dysfunction-associated steatotic liver disease by reducing de novo lipogenesis in a mouse model of lipoatrophic diabetes.

Smati S, Sotin T, Deniel P, Ducheix S, Joubert M, Arnaud L, Hadjadj S, Cariou B, Le May C, Prieur X. Smati S, et al. Among authors: hadjadj s. Diabetes Obes Metab. 2024 May 3. doi: 10.1111/dom.15634. Online ahead of print. Diabetes Obes Metab. 2024. PMID: 38699785 No abstract available.

2

Aldosterone synthase inhibitor (BI 690517) therapy for people with diabetes and albuminuric chronic kidney disease: A multicentre, randomized, double-blind, placebo-controlled, Phase I trial.

Bornstein SR, de Zeeuw D, Heerspink HJL, Schulze F, Cronin L, Wenz A, Tuttle KR, Hadjadj S, Rossing P. Bornstein SR, et al. Among authors: hadjadj s. Diabetes Obes Metab. 2024 Jun;26(6):2128-2138. doi: 10.1111/dom.15518. Epub 2024 Mar 18. Diabetes Obes Metab. 2024. PMID: 38497241 Clinical Trial.

3

Empagliflozin and Rapid Kidney Function Decline Incidence in Type 2 Diabetes: An Exploratory Analysis From the EMPA-REG OUTCOME Trial.

Hadjadj S, Cooper ME, Steubl D, Petrini M, Hantel S, Mattheus M, Wanner C, Thomas MC. Hadjadj S, et al. Kidney Med. 2023 Dec 18;6(3):100783. doi: 10.1016/j.xkme.2023.100783. eCollection 2024 Mar. Kidney Med. 2023. PMID: 38419787 Free PMC article.

4

Primary hypocholesterolemia is associated with an increased risk of hepatic complications in the general population.

Wargny M, Goronflot T, Rimbert A, Boursier J, Kab S, Henny J, Lainé A, Leux C, Smati S, Hadjadj S, Le May C, Goldberg M, Zins M, Cariou B. Wargny M, et al. Among authors: hadjadj s. J Hepatol. 2024 Feb 6:S0168-8278(24)00108-9. doi: 10.1016/j.jhep.2024.01.030. Online ahead of print. J Hepatol. 2024. PMID: 38331324 Free article.

5

QRS-T angle: is it a specific parameter associated with sudden cardiac death in type 2 diabetes? Results from the SURDIAGENE and the Mini-Finland prospective cohorts.

Garcia R, Schröder LC, Tavernier M, Gand E, de Keizer J, Holkeri A, Eranti A, Bidegain N, Alos B, Junttila J, Knekt P, Roumegou P, Gamet A, Bouleti C, Degand B, Ragot S, Hadjadj S, Aro AL, Saulnier PJ; SURDIAGENE and the Mini-Finland study groups. Garcia R, et al. Among authors: hadjadj s. Diabetologia. 2024 Apr;67(4):641-649. doi: 10.1007/s00125-023-06074-4. Epub 2024 Jan 24. Diabetologia. 2024. PMID: 38267653

6

Blood Monocyte Phenotype Is A Marker of Cardiovascular Risk in Type 2 Diabetes.

Julla JB, Girard D, Diedisheim M, Saulnier PJ, Tran Vuong B, Blériot C, Carcarino E, De Keizer J, Orliaguet L, Nemazanyy I, Potier C, Khider K, Tonui DC, Ejlalmanesh T, Ballaire R, Mambu Mambueni H, Germain S, Gaborit B, Vidal-Trécan T, Riveline JP, Garchon HJ, Fenaille F, Lemoine S, Carlier A, Castelli F, Potier L, Masson D, Roussel R, Vandiedonck C, Hadjadj S, Alzaid F, Gautier JF, Venteclef N. Julla JB, et al. Among authors: hadjadj s. Circ Res. 2024 Jan 19;134(2):189-202. doi: 10.1161/CIRCRESAHA.123.322757. Epub 2023 Dec 28. Circ Res. 2024. PMID: 38152893 Free article.

7

Single-anastomosis duodeno-ileal bypass with sleeve gastrectomy improves lipid and glucose homeostasis in ob/ob mice.

Frey S, Ayer A, Sotin T, Lorant V, Louis-Gaubert C, Arnaud L, Billon-Crossouard S, Croyal M, Prieur X, Hadjadj S, Cariou B, Blanchard C, Le May C. Frey S, et al. Among authors: hadjadj s. Obesity (Silver Spring). 2024 Jan;32(1):91-106. doi: 10.1002/oby.23916. Epub 2023 Oct 24. Obesity (Silver Spring). 2024. PMID: 37875256

8

Atherosclerotic cardiovascular disease risk stratification and management in type 2 diabetes: review of recent evidence-based guidelines.

Gourdy P, Schiele F, Halimi JM, Kownator S, Hadjadj S, Valensi P. Gourdy P, et al. Among authors: hadjadj s. Front Cardiovasc Med. 2023 Sep 26;10:1227769. doi: 10.3389/fcvm.2023.1227769. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37829695 Free PMC article. Review.

9

Severity of kidney involvement as predictor of death, severe heart failure and renal events in patients with type 2 diabetes: Data from a prospective cohort.

Hadjadj S, Saulnier PJ, Cariou B; SURDIAGENE study investigators. Hadjadj S, et al. Presse Med. 2023 Mar;52(1):104177. doi: 10.1016/j.lpm.2023.104177. Epub 2023 Oct 4. Presse Med. 2023. PMID: 37802241

10

Connexin-43 hemichannels orchestrate NOD-like receptor protein-3 (NLRP3) inflammasome activation and sterile inflammation in tubular injury.

Roger E, Chadjichristos CE, Kavvadas P, Price GW, Cliff CL, Hadjadj S, Renciot J, Squires PE, Hills CE. Roger E, et al. Among authors: hadjadj s. Cell Commun Signal. 2023 Sep 28;21(1):263. doi: 10.1186/s12964-023-01245-7. Cell Commun Signal. 2023. PMID: 37770948 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

313 results

Search Page